Interventional Tools

PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

The Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace, NOT-MH-21-125, encourages the translation of BRAIN Initiative-supported technologies from academic and other non-small business research sectors to the marketplace.

PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

The Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace, NOT-MH-21-125, encourages the translation of BRAIN Initiative-supported technologies from academic and other non-small business research sectors to the marketplace.

Addgene Launches Open Access Recombinant Antibody Resource for the Scientific Research Community

Addgene, the nonprofit biorepository, now produces and distributes ready-to-use recombinant antibodies. The inaugural collection of monoclonal antibodies is part of the Neuroscience AntiBody Open Resource (NABOR), a platform that provides open access to recombinant antibodies and affinity reagents for the neuroscience community. NABOR is supported by a grant from the National Institutes of Health’s Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative.